FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308150903> ?p ?o ?g. }

• W4308150903 endingPage "e11359" @default.
• W4308150903 startingPage "e11359" @default.
• W4308150903 abstract "A critical target in age-related macular degeneration (AMD) is the retinal pigment epithelium (RPE), which forms the outer blood-retina barrier (BRB). RPE-barrier dysfunction might result from the disruption of intercellular tight junctions (TJs). A Connexin43 (Cx43)-based peptide, aCT1, has been shown to prevent VEGF-induced loss of transepithelial resistance, choroidal neovascularization (CNV) and RPE-cell damage via the stabilization of TJs. Here, we probe the relative efficacies of aCT1 alone, anti-VEGF alone, and aCT1 with anti-VEGF in treating AMD pathologies. aCT1 monotherapy administered as topical eye drops with and without a VEGF blocking antibody administered systemically was tested in a mouse model of laser-induced CNV. The CNV mouse is the standard neovascular AMD model, reproducing hallmarks of its pathology. CNV lesion size and fluid accumulation were assessed using optical coherence tomography. During the angiogenesis phase of CNV lesion development, single applications of anti-VEGF or aCT1 reduced lesion and fluid dome size equally. The combinatorial aCT1/anti-VEGF strategy demonstrated lack of additive effects in this model. These data suggest that TJ stabilization by aCT1 is effective in ameliorating RPE dysfunction in a model of AMD-like angiogenesis, and that this strategy is as effective as the current clinical standard of care, anti-VEGF therapy. Critically, aCT1 holds potential as a new neovascular AMD treatment that can be administered using eye drops, which is preferable to the intravitreal injections required for standard anti-VEGF therapy." @default.
• W4308150903 created "2022-11-08" @default.
• W4308150903 creator A5012920949 @default.
• W4308150903 creator A5044957095 @default.
• W4308150903 creator A5050439573 @default.
• W4308150903 creator A5055321629 @default.
• W4308150903 date "2022-11-01" @default.
• W4308150903 modified "2023-09-26" @default.
• W4308150903 title "Evaluation of a connexin-based peptide for the treatment of age-related macular degeneration" @default.
• W4308150903 cites W1571506644 @default.
• W4308150903 cites W1702382101 @default.
• W4308150903 cites W1942442866 @default.
• W4308150903 cites W1960493235 @default.
• W4308150903 cites W1967354672 @default.
• W4308150903 cites W1984056827 @default.
• W4308150903 cites W1992517723 @default.
• W4308150903 cites W1997772006 @default.
• W4308150903 cites W2010499532 @default.
• W4308150903 cites W2020499836 @default.
• W4308150903 cites W2025576158 @default.
• W4308150903 cites W2041809552 @default.
• W4308150903 cites W2054899478 @default.
• W4308150903 cites W2057185572 @default.
• W4308150903 cites W2082335148 @default.
• W4308150903 cites W2092638574 @default.
• W4308150903 cites W2095238429 @default.
• W4308150903 cites W2097746741 @default.
• W4308150903 cites W2118450542 @default.
• W4308150903 cites W2131536417 @default.
• W4308150903 cites W2145027330 @default.
• W4308150903 cites W2161400914 @default.
• W4308150903 cites W2283773678 @default.
• W4308150903 cites W2322911088 @default.
• W4308150903 cites W2407590409 @default.
• W4308150903 cites W2551977585 @default.
• W4308150903 cites W2565136318 @default.
• W4308150903 cites W2578846619 @default.
• W4308150903 cites W2580008828 @default.
• W4308150903 cites W2770518620 @default.
• W4308150903 cites W2772015451 @default.
• W4308150903 cites W2900022657 @default.
• W4308150903 cites W2911888004 @default.
• W4308150903 cites W2965152158 @default.
• W4308150903 cites W2967162556 @default.
• W4308150903 cites W2994865070 @default.
• W4308150903 cites W3012834768 @default.
• W4308150903 cites W3015361066 @default.
• W4308150903 cites W3107267545 @default.
• W4308150903 cites W4206202146 @default.
• W4308150903 cites W4290793427 @default.
• W4308150903 cites W2130023114 @default.
• W4308150903 cites W2166889426 @default.
• W4308150903 doi "https://doi.org/10.1016/j.heliyon.2022.e11359" @default.
• W4308150903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36387470" @default.
• W4308150903 hasPublicationYear "2022" @default.
• W4308150903 type Work @default.
• W4308150903 citedByCount "1" @default.
• W4308150903 countsByYear W43081509032023 @default.
• W4308150903 crossrefType "journal-article" @default.
• W4308150903 hasAuthorship W4308150903A5012920949 @default.
• W4308150903 hasAuthorship W4308150903A5044957095 @default.
• W4308150903 hasAuthorship W4308150903A5050439573 @default.
• W4308150903 hasAuthorship W4308150903A5055321629 @default.
• W4308150903 hasBestOaLocation W43081509031 @default.
• W4308150903 hasConcept C118487528 @default.
• W4308150903 hasConcept C142724271 @default.
• W4308150903 hasConcept C158157758 @default.
• W4308150903 hasConcept C167734588 @default.
• W4308150903 hasConcept C169760540 @default.
• W4308150903 hasConcept C177779419 @default.
• W4308150903 hasConcept C2776403814 @default.
• W4308150903 hasConcept C2777025900 @default.
• W4308150903 hasConcept C2777093970 @default.
• W4308150903 hasConcept C2778024200 @default.
• W4308150903 hasConcept C2778271429 @default.
• W4308150903 hasConcept C2780228694 @default.
• W4308150903 hasConcept C2780394083 @default.
• W4308150903 hasConcept C2780827179 @default.
• W4308150903 hasConcept C2781156865 @default.
• W4308150903 hasConcept C2781359195 @default.
• W4308150903 hasConcept C502942594 @default.
• W4308150903 hasConcept C71924100 @default.
• W4308150903 hasConcept C79879829 @default.
• W4308150903 hasConcept C86803240 @default.
• W4308150903 hasConcept C95444343 @default.
• W4308150903 hasConceptScore W4308150903C118487528 @default.
• W4308150903 hasConceptScore W4308150903C142724271 @default.
• W4308150903 hasConceptScore W4308150903C158157758 @default.
• W4308150903 hasConceptScore W4308150903C167734588 @default.
• W4308150903 hasConceptScore W4308150903C169760540 @default.
• W4308150903 hasConceptScore W4308150903C177779419 @default.
• W4308150903 hasConceptScore W4308150903C2776403814 @default.
• W4308150903 hasConceptScore W4308150903C2777025900 @default.
• W4308150903 hasConceptScore W4308150903C2777093970 @default.
• W4308150903 hasConceptScore W4308150903C2778024200 @default.
• W4308150903 hasConceptScore W4308150903C2778271429 @default.
• W4308150903 hasConceptScore W4308150903C2780228694 @default.
• W4308150903 hasConceptScore W4308150903C2780394083 @default.

• next